LIFESTANCE HEALTH GROUP INC (LFST)
Health Care · healthcare services · NASDAQ
LifeStance Health is a mental healthcare platform providing accessible, integrated outpatient behavioral health services through both in-person and virtual channels.
What LIFESTANCE HEALTH GROUP INC does
LifeStance Health Group, Inc. operates a mental healthcare platform that provides in-person and virtual outpatient care. The company partners with clinicians and health systems to offer services including psychiatry, psychology, and therapy, focusing on expanding patient access to behavioral health through a network of centers.
Themes: behavioral health, telehealth, mental health services
Fundamentals
- Price$12.47 as of 2026-08-21 close
- Market cap$4.8B as of 2026-08-21
- 1-year return+126.7% 2025-08-21 close $5.50 → 2026-08-21 close $12.47
- P/E201.26 as of 2026-08-24
- Net margin+1.6% as of 2026-08-24
- ROE+1.6% as of 2026-08-24
- Debt / equity0.19 as of 2026-08-24
- Revenue growth (YoY)-12.8% as of 2026-08-24
- Revenue CAGR (3y)+18.3% SEC XBRL
- Beta1.23 as of 2026-08-24
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
How LFST compares in its sector
- price-to-earnings ratiotop 10% 203 covered Health Care peers, as of 2026-08-24
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- return on equitymiddle range 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
LFST is not currently in any published Top 10 list. Its scores are below.
Long-term score
Not scored for the long-term list: no shareholder return data.
Short-term score
64.1 #75 of 1,704 scored · #25 of 240 in Health Care
Trend 85th: a strong uptrend, with buyers in control; catalysts 78th: analysts have raised their average price target by 7.0% since the prior reading; weakest is setup 37th: day-to-day price swings are unusually wide versus its own recent history (wider than about 85% of the past ~6 months).
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
How LIFESTANCE HEALTH GROUP INC looks technically
LIFESTANCE HEALTH GROUP INC (LFST) is trading 58.2% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 175 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 40, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 64, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 8 trading days ago (its momentum flipped positive). It made a new 20-day high about 3 trading days ago. It is 3.8% below its 52-week high (its highest price of the past year).
Trend
8
| Distance from the 200-day | it is trading 58.2% above its 200-day average, the long-term trend line — a longer-term uptrend | +58.2% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $10.72 | $10.72 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $7.88 | $7.88 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 32 calendar days ago — the swings before that are what the structure reading is measured on | 32 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 7.98. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible upward five-wave sequence, in wave 4 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 175 trading days ago — a "golden cross", a bullish long-term signal | 175 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 40, with buyers in control | 40.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 64, neither overbought (above 70) nor oversold (below 30) | 63.7 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($10.08 to $12.96) — its "stochastic" reading is 83 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 82.8 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 8 trading days ago (its momentum flipped positive) | 8 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $12.96 | $12.96 |
|---|---|---|
| From the 52-week high | it is 3.8% below its 52-week high (its highest price of the past year) | -3.8% |
| Above the 52-week low | it is 161.4% above its 52-week low (its lowest price of the past year) | +161.4% |
| Below the 52-week high | it is 3.8% below its highest point of the past year | 3.8% |
| Since a 20-day breakout | it made a new 20-day high about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day high about 3 trading days ago | 3 sessions |
| All-time high | its highest closing price on record is $29.81 (set on 2021-07-07) | $29.81 |
| Given back of the 52-week move | over the past year its closes ranged ($4.81 to $12.83), and it has given back only a small part of its rise from last year’s low — 4% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $7.62 to $7.87. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 4.5% |
| From the all-time high | it is 58.2% below its all-time high | -58.2% |
| Nearest price level | it is trading 6.3% above a support level at $11.69 — a price it turned at twice since 2026-07-02, most recently on 2026-07-20. Since 2024-08-21 it has 14 such levels below the current price and 0 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -6.3% |
| All-time low | its lowest closing price on record is $3.74 (set on 2025-08-01) | $3.74 |
| Above the all-time low | it is 233.4% above its all-time low | +233.4% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 85% of the past ~6 months) | 85th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.4926 between its high and its low — about 4.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.4926 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $9.75 and $13.25 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $9.75 – $11.50 – $13.25 |
| Typical daily range (% of price) | its price moves about 4.0% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.0% |
| Stretch from the 200-day average | it is trading 9.3 daily ranges above its 200-day average price (58.2% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 9.3 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.68× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 7.0% since the prior reading | +7.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating has improved toward "buy" since the prior reading | 0.05 toward buy |
Candlestick patterns
1
| Since a bearish engulfing | 3 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 3 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-21 at essentially the same price it closed at the session before — no meaningful overnight gap | 0.0% |
|---|---|---|
| Open gap | it gapped 2.8% above the previous close 2 sessions ago and has not traded back through the level it left behind at 12.36 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.8% |
| Gap filled | a 2.3% gap up opened on 2026-08-07 has been "filled" 10 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 10 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -2.81% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 6.6 percentage points (the stock gained 8.9% while the market gained 2.3%) | +6.6% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 64.1 percentage points (the stock gained 67.2% while the market gained 3.1%) | +64.1% |
| vs market, 6 months | over the past 6 months this stock beat the market by 63.3 percentage points (the stock gained 74.4% while the market gained 11.1%) | +63.3% |
| vs market, 12 months | over the past 12 months this stock beat the market by 106.2 percentage points (the stock gained 126.7% while the market gained 20.5%) | +106.3% |
Signal agreement
2
| Bullish technical signals | 7 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 7 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 22% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-15 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 6.7% of the share price. | +21.9% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 45% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $8.61 — a volume-weighted average of daily closes over 159 sessions, not a true tick-by-tick VWAP. | +44.9% |
|---|---|---|
| Vs the average paid since it last reported | the price is 5% above the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $11.87 — a volume-weighted average of daily closes over 12 sessions, not a true tick-by-tick VWAP. | +5.1% |
Price levels it has turned at before
LFST last closed at $12.47 on 2026-08-21. Since 2024-08-21 it has turned at 14 prices below its last close and 0 above; the 3 nearest below are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $11.69 | Support | 6.3% below the last close | turned there twice · 2026-07-02 to 2026-07-20 |
| $8.21 | Support | 34.2% below the last close | turned there four times · 2025-01-28 to 2026-02-25 |
| $7.97 | Support | 36.1% below the last close | turned there twice · 2025-01-06 to 2026-06-02 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $7.98.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
On past moves of this shape the leg has usually ended somewhere between $9.53 and $10.71 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Broke out to a new 20-day high · in a strong, established uptrend (ADX) · Analyst price target recently RAISED · beating the market · Stretched far above its 200-day average (6+ daily ranges) | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.55 mean, 1=Strong Buy…5=Strong Sell) — 10 analysts
- Mean price target$13.80 range $12.00 – $18.00; median $13.00
Analyst estimates, as of 2026-08-22. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for LFST
- Consensus EPS estimate$0.09988 next reporting period, as of 2026-08-22
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["dependence on third-party payor reimbursement rates","reliance on ability to recruit and retain clinicians","risks associated with managing growth and regulatory compliance in a heavily regulated industry"]
What changed in the latest 10-Q
AI-assisted comparison of LFST's 10-Q filed 2026-05-07 against the prior one filed 2025-11-06.
Management's Discussion & Analysis (MD&A)
- Added:
- New opening phrase in business description: 'We are dedicated to improving the lives of our patients by reimagining mental health' (2026-05-07 filing)
- Reworded:
- Business description opening changed from 'We are reimagining mental health through a tech-enabled care delivery model' (2025-11-06) to 'We are dedicated to improving the lives of our patients by reimagining mental health through a tech-enabled in-person and virtual care delivery model' (2026-05-07)
- Clinician count updated from '7,996 licensed mental health clinicians as of September 30, 2025' (2025-11-06) to '8,349 licensed mental health clinicians as of March 31, 2026' (2026-05-07)
- Reference date for clinician count changed from 'as of September 30, 2025' to 'as of March 31, 2026' (2026-05-07)
- Reference to Form 10-K year changed from 'for the year ended December 31, 2024' (2025-11-06) to 'for the year ended December 31, 2025' (2026-05-07)
- OBBBA reference wording changed from 'OBBBA is not expected' (2025-11-06) to 'the OBBBA is not expected' (2026-05-07)
- Clinician count in 'Our Clinicians' section updated from '7,996 psychiatrists, advanced practice nurses, psychologists and therapists as of September 30, 2025' (2025-11-06) to '8,349 psychiatrists, advanced practice nurses, psychologists and therapists as of March 31, 2026' (2026-05-07)
- Notes:
- Newer filing text appears truncated at end of 'Our Clinicians' section; older filing similarly truncated; comparison limited to complete passages
Risk Factors
- Added:
- New reference to 10-K for year ended December 31, 2025 filed February 25, 2026 (in forward-looking statements section) [newer filing 2026-05-07]
- New bullet point: 'our growth depends on our ability to recruit, acquire and retain clinicians' [newer filing 2026-05-07]
- New bullet point: 'our business depends on our ability to effectively invest in, implement improvements to and properly maintain the uninterrupted operation and data integrity of our information technology and other business systems' [newer filing 2026-05-07]
- New bullet point: 'if we are unable to adapt to healthcare reform legislation and other changes in the healthcare industry and in healthcare spending, our business could be harmed' [newer filing 2026-05-07]
- Removed:
- Reference to 10-K for year ended December 31, 2024 filed February 27, 2025 (replaced with 2025 10-K reference) [older filing 2025-11-06]
- Bullet point: 'our ability to recruit new clinicians and retain existing clinicians' (replaced with different wording) [older filing 2025-11-06]
- Bullet point: 'the impact on us of healthcare reform legislation and other changes in the healthcare industry and in healthcare spending is currently unknown, but may harm our business' (replaced with different wording) [older filing 2025-11-06]
- Reworded:
- Order of risk factor bullets changed: 'competitiveness' moved earlier in list, 'IT systems' moved later, and 'healthcare reform' reworded and repositioned [newer filing 2026-05-07 vs older filing 2025-11-06]
- Changed from 'our ability to recruit new clinicians and retain existing clinicians' to 'our growth depends on our ability to recruit, acquire and retain clinicians' - adds 'acquire' and changes framing [newer filing 2026-05-07]
- Changed from 'the impact on us of healthcare reform legislation and other changes in the healthcare industry and in healthcare spending is currently unknown, but may harm our business' to 'if we are unable to adapt to healthcare reform legislation and other changes in the healthcare industry and in healthcare spending, our business could be harmed' - shifts from unknown impact to adaptation focus [newer filing 2026-05-07]
- Notes:
- Financial statements section shown contains only balance sheets and partial income statement data; full Risk Factors section (Item 1A) content not provided in either filing excerpt, limiting assessment to forward-looking statements and bullet points only
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 2 open-market sales by insiders in the last 90 days.
- Last 90 days0 buys · 2 sells ($9M) — 1 selling insider
- Last 180 days0 buys · 15 sells ($291M) — 4 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-26. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about LFST's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding LFST as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 85,577,351
- Reported value $545,127,724
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 4 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
LFST had 9,571,642 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
LFST had 2.51% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.5 days to cover at the same settlement.
- Reported short interest (shares) 9,571,642
- Short interest (% of shares outstanding) 2.51%
- Prior settlement (shares) 9,460,426
- Reported change 1.18%
- Days to cover (reported) 3.5
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Talkspace (TALK)
- Hims & Hers Health (HIMS)
- Teladoc Health (TDOC)
- Acadia Healthcare (ACHC)
- Universal Health Services (UHS)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare LFST vs…
Frequently asked questions
What does LIFESTANCE HEALTH GROUP INC (LFST) do?
LifeStance Health Group, Inc. operates a mental healthcare platform that provides in-person and virtual outpatient care. The company partners with clinicians and health systems to offer services including psychiatry, psychology, and therapy, focusing on expanding patient access to behavioral health through a network of centers.
What sector is LIFESTANCE HEALTH GROUP INC (LFST) in?
LIFESTANCE HEALTH GROUP INC (LFST) is classified in the Health Care sector. Its industry is healthcare services. It trades on NASDAQ.
Who are LIFESTANCE HEALTH GROUP INC's (LFST) competitors?
Notable peers of LIFESTANCE HEALTH GROUP INC (LFST) include Talkspace, Hims & Hers Health, Teladoc Health, Acadia Healthcare and Universal Health Services. This peer set is informational only — not financial advice.
Is LIFESTANCE HEALTH GROUP INC (LFST) overbought or oversold right now?
LIFESTANCE HEALTH GROUP INC (LFST) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 64, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on LFST come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.